Literature DB >> 32573137

[Efficacy of clarithromycin in the adjuvant treatment of chronic periodontitis: a Meta-analysis].

Yin Bai1, Yuan-Liang Bai1, Jing Lai1, Jiao Huang1.   

Abstract

OBJECTIVE: To evaluate the clinical efficacy of clarithromycin (CLM) in the adjuvant treatment of chronic periodontitis systematically, obtain reasonable conclusions through evidence-based medicine, and provide guidance for clinical rational drug use.
METHODS: Literature about CLM in the adjuvant treatment of chronic periodontitis was searched in CNKI, VIP, Wanfang, Chinese Biomedical Literature Database, PubMed, ScienceDirect, and Embase databases from inception to February 2019 using a computer. Meta-analysis was performed on the homogeneous study using RevMan 5.3 software after two independent reviewers screened the literature, evaluated the quality of the study, extracted the data, and evaluated the risk of bias in the included studies.
RESULTS: Six randomized controlled trials were included in 316 subjects. The meta-analysis showed that compared with the scaling and root planning (SRP) group, the probing depth (PD) was reduced in patients with CLM and SRP [MD=-1.00, 95%CI (-1.55, -0.45), P=0.000 04]. Clinical attachment loss was obtained [MD=-0.03, 95%CI (0.43, 0.65), P<0.000 01], and the difference between the groups was statistically significant. The modified sulcus bleeding index (mSBI) was reduced [MD=-0.01, 95%CI (-0.14, 0.19), P=0.66]. No significant difference was observed between the groups, but the decrease in mSBI was more significant in CLM combined with SRP group.
CONCLUSIONS: CLM combined with subgingival SRP can achieve remarkable results in treating chronic periodontitist.

Entities:  

Keywords:  Meta-analysis; chronic periodontitis; clarithromycin; non-surgical periodontal therapy

Mesh:

Substances:

Year:  2020        PMID: 32573137      PMCID: PMC7296377          DOI: 10.7518/hxkq.2020.03.011

Source DB:  PubMed          Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi        ISSN: 1000-1182


  25 in total

1.  Anti-inflammatory activity of clarithromycin in adults with chronically inflamed sinus mucosa.

Authors:  C M MacLeod; Q A Hamid; L Cameron; C Tremblay; W Brisco
Journal:  Adv Ther       Date:  2001 Mar-Apr       Impact factor: 3.845

Review 2.  CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials.

Authors:  David Moher; Sally Hopewell; Kenneth F Schulz; Victor Montori; Peter C Gøtzsche; P J Devereaux; Diana Elbourne; Matthias Egger; Douglas G Altman
Journal:  Int J Surg       Date:  2011-10-12       Impact factor: 6.071

3.  The effect of plaque control and surgical pocket elimination on the establishment and maintenance of periodontal health. A longitudinal study of periodontal therapy in cases of advanced disease.

Authors:  J Lindhe; S Nyman
Journal:  J Clin Periodontol       Date:  1975-04       Impact factor: 8.728

4.  Activities of telithromycin (HMR 3647, RU 66647) compared to those of erythromycin, azithromycin, clarithromycin, roxithromycin, and other antimicrobial agents against unusual anaerobes.

Authors:  E J Goldstein; D M Citron; C V Merriam; Y Warren; K Tyrrell
Journal:  Antimicrob Agents Chemother       Date:  1999-11       Impact factor: 5.191

5.  Efficacy of local drug delivery of 0.5% clarithromycin gel as an adjunct to non-surgical periodontal therapy in the treatment of current smokers with chronic periodontitis: a randomized controlled clinical trial.

Authors:  Esha Agarwal; A R Pradeep; Pavan Bajaj; Savitha B Naik
Journal:  J Periodontol       Date:  2012-01-16       Impact factor: 6.993

6.  Effect of clarithromycin on rhinovirus-16 infection in A549 cells.

Authors:  Y J Jang; H-J Kwon; B-J Lee
Journal:  Eur Respir J       Date:  2006-01       Impact factor: 16.671

7.  Clarithromycin, as an adjunct to non surgical periodontal therapy for chronic periodontitis: a double blinded, placebo controlled, randomized clinical trial.

Authors:  A R Pradeep; Rahul Kathariya
Journal:  Arch Oral Biol       Date:  2011-05-06       Impact factor: 2.633

8.  Azithromycin and clarithromycin inhibit lipopolysaccharide-induced murine pulmonary neutrophilia mainly through effects on macrophage-derived granulocyte-macrophage colony-stimulating factor and interleukin-1beta.

Authors:  Martina Bosnar; Berislav Bosnjak; Snjezana Cuzic; Boska Hrvacic; Nikola Marjanovic; Ines Glojnaric; Ognjen Culic; Michael J Parnham; Vesna Erakovic Haber
Journal:  J Pharmacol Exp Ther       Date:  2009-07-24       Impact factor: 4.030

9.  Full-mouth ultrasonic debridement associated with amoxicillin and metronidazole in the treatment of severe chronic periodontitis.

Authors:  Erica Del Peloso Ribeiro; Sandro Bittencourt; Iriana Carla Junqueira Zanin; Glaucia Maria Bovi Ambrosano; Enilson A Sallum; Francisco H Nociti; Reginaldo Bruno Gonçalves; Márcio Zaffalon Casati
Journal:  J Periodontol       Date:  2009-08       Impact factor: 6.993

10.  Distribution of systemic clarithromycin to gingiva.

Authors:  Renita C Burrell; John D Walters
Journal:  J Periodontol       Date:  2008-09       Impact factor: 6.993

View more
  1 in total

1.  Analysis of the Effect of DPL Combined with Clarithromycin in the Therapy and Improvement of Rosacea.

Authors:  Fang Yan; Chao Peng
Journal:  Contrast Media Mol Imaging       Date:  2022-08-19       Impact factor: 3.009

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.